{"id":"https://openalex.org/W180779010","doi":null,"title":"Ethical considerations in relation to aspirin prophylaxis.","display_name":"Ethical considerations in relation to aspirin prophylaxis.","publication_year":2008,"publication_date":"2008-01-01","ids":{"openalex":"https://openalex.org/W180779010","mag":"180779010","pmid":"https://pubmed.ncbi.nlm.nih.gov/19094419"},"language":"en","primary_location":{"id":"pmid:19094419","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19094419","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Quality in primary care","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102849724","display_name":"Gareth Morgan","orcid":"https://orcid.org/0000-0003-0429-6294","observed_orcids":["https://orcid.org/0000-0003-0429-6294","https://orcid.org/0000-0001-7884-1131"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Gareth Morgan","raw_affiliation_strings":["Welsh Aspirin Group Secretary, Swansea, Wales, UK. morgan@fforrdbeck.fsnet.co.uk"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Welsh Aspirin Group Secretary, Swansea, Wales, UK. morgan@fforrdbeck.fsnet.co.uk","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5102849724"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.4131,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.82926282,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"16","issue":"6","first_page":"433","last_page":"40"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.9833999872207642,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.9833999872207642,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.009100000374019146,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13147","display_name":"Ethics and bioethics in healthcare","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aspirin-prophylaxis","display_name":"aspirin prophylaxis","score":0.8930000066757202},{"id":"https://openalex.org/keywords/low-dose-aspirin","display_name":"low-dose aspirin","score":0.9620000123977661},{"id":"https://openalex.org/keywords/ethical-issues","display_name":"ethical considerations","score":0.5730000138282776},{"id":"https://openalex.org/keywords/benefit-risk-balance","display_name":"benefit-risk balance","score":0.7680000066757202},{"id":"https://openalex.org/keywords/gastric-hemorrhage","display_name":"gastric bleeding","score":0.8560000061988831},{"id":"https://openalex.org/keywords/risk-compensation","display_name":"risk compensation","score":0.9340000152587891},{"id":"https://openalex.org/keywords/iatrogenesis","display_name":"iatrogenesis","score":0.9959999918937683},{"id":"https://openalex.org/keywords/health-disparities","display_name":"health disparities","score":0.9750000238418579},{"id":"https://openalex.org/keywords/vascular-events","display_name":"vascular events","score":0.7260000109672546},{"id":"https://openalex.org/keywords/cancer-risk-reduction","display_name":"cancer risk reduction","score":0.8569999933242798},{"id":"https://openalex.org/keywords/drug-policy","display_name":"drug policy","score":0.656000018119812}],"concepts":[{"id":"https://openalex.org/C2777628954","wikidata":"https://www.wikidata.org/wiki/Q18216","display_name":"Aspirin","level":2,"score":0.8934255838394165},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7227001786231995},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.576031506061554},{"id":"https://openalex.org/C2776259030","wikidata":"https://www.wikidata.org/wiki/Q769508","display_name":"Bleed","level":2,"score":0.5635803937911987},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.5472452640533447},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.43612125515937805},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.21727055311203003},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.1717396080493927},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.14740443229675293}],"mesh":[{"descriptor_ui":"D000367","descriptor_name":"Age Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001241","descriptor_name":"Aspirin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001241","descriptor_name":"Aspirin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001241","descriptor_name":"Aspirin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004992","descriptor_name":"Ethics, Medical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006471","descriptor_name":"Gastrointestinal Hemorrhage","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D010975","descriptor_name":"Platelet Aggregation Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010975","descriptor_name":"Platelet Aggregation Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010975","descriptor_name":"Platelet Aggregation Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012959","descriptor_name":"Socioeconomic Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:19094419","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19094419","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Quality in primary care","raw_type":"Journal Article"},{"id":"pmh:oai:repository.library.georgetown.edu:10822/960176","doi":null,"is_oa":false,"landing_page_url":"http://worldcatlibraries.org/registry/gateway?version=1.0&url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&atitle=Ethical+considerations+in+relation+to+aspirin+prophylaxis.&title=Quality+in+Primary+Care+&volume=16&issue=6&date=2008&au=Morgan,+Gareth","pdf_url":null,"source":{"id":"https://openalex.org/S4306402467","display_name":"DigitalGeorgetown (Georgetown University Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210145449","host_organization_name":"Center for Security and Emerging Technology","host_organization_lineage":["https://openalex.org/I4210145449"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"eweb:312764","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W1523395670","https://openalex.org/W1907953089","https://openalex.org/W1955473499","https://openalex.org/W1970978436","https://openalex.org/W1978752188","https://openalex.org/W1987387966","https://openalex.org/W1994010716","https://openalex.org/W1996185891","https://openalex.org/W2010518325","https://openalex.org/W2020709168","https://openalex.org/W2022175608","https://openalex.org/W2023612063","https://openalex.org/W2036076105","https://openalex.org/W2051818429","https://openalex.org/W2052001458","https://openalex.org/W2057544790","https://openalex.org/W2060556093","https://openalex.org/W2068413739","https://openalex.org/W2079126629","https://openalex.org/W2082394989","https://openalex.org/W2095095509","https://openalex.org/W2096721824","https://openalex.org/W2109585014","https://openalex.org/W2122829172","https://openalex.org/W2125140809","https://openalex.org/W2135201083","https://openalex.org/W2142532695","https://openalex.org/W2146644337","https://openalex.org/W2165677177","https://openalex.org/W2167228413","https://openalex.org/W2184857919"],"related_works":["https://openalex.org/W2168926300","https://openalex.org/W2058838014","https://openalex.org/W2387727724","https://openalex.org/W2319937628","https://openalex.org/W2116424049","https://openalex.org/W2163295564","https://openalex.org/W1977208887","https://openalex.org/W4389135778","https://openalex.org/W2090402165","https://openalex.org/W1993999811"],"abstract_inverted_index":{"Low-dose":[0],"aspirin":[1,31,63],"prophylaxis,":[2],"75-150":[3],"mg":[4],"per":[5],"day,":[6],"reduces":[7],"the":[8,24,37,40,58,65,69,76,108,112],"risk":[9,25,41,74],"of":[10,26,30,42,62,71,75,111],"vascular":[11,125],"events":[12],"and":[13,73,85,106],"there":[14],"is":[15,47,98],"also":[16,22],"promising":[17],"evidence":[18,115],"that":[19],"it":[20],"may":[21,32],"reduce":[23],"cancer.":[27],"Increased":[28],"use":[29,61,110],"confer":[33],"considerable":[34],"benefits":[35],"to":[36,57,104,132],"population,":[38],"but":[39],"causing":[43],"a":[44,49,90],"gastric":[45],"bleed":[46],"certainly":[48],"major":[50],"concern.":[51],"There":[52],"are":[53],"ethical":[54],"considerations":[55],"related":[56],"potential":[59,91],"increased":[60],"in":[64],"population.":[66],"These":[67],"include":[68],"balance":[70],"benefit":[72],"medicine,":[77],"possible":[78],"undesirable":[79],"effects":[80],"such":[81],"as":[82,87,89],"'risk":[83],"compensation'":[84],"'iatrogenesis',":[86],"well":[88],"impact":[92],"on":[93,101,116,124],"health":[94],"inequalities.":[95],"More":[96,114],"research":[97],"therefore":[99],"needed":[100],"aspirin,":[102,117],"particularly":[103],"define":[105],"describe":[107],"population":[109],"drug.":[113],"including":[118],"an":[119],"ongoing":[120],"randomised":[121],"controlled":[122],"trial":[123],"events,":[126],"will":[127],"allow":[128],"appropriate":[129],"policy":[130],"responses":[131],"be":[133],"made.":[134]},"counts_by_year":[{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}